AAAAAA
Results:
1-12
|
Results: 12
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Ancione, M
Madia, AG
Perucca, E
Citation: E. Spina et al., Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophrenia, PSYCHOPHAR, 153(2), 2001, pp. 238-243
Authors:
Campo, GM
Squadrito, F
Ceccarelli, S
Calo, M
Avenoso, A
Campo, S
Squadrito, G
Altavilla, D
Citation: Gm. Campo et al., Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant, FREE RAD RE, 34(4), 2001, pp. 379
Authors:
Spina, E
Scordo, MG
Avenoso, A
Perucca, E
Citation: E. Spina et al., Adverse drug interaction between risperidone and carbamazepine in a patient with chronic schizophrenia and deficient CYP2D6 activity, J CL PSYCH, 21(1), 2001, pp. 108-109
Authors:
Spina, E
Avenoso, A
Scordo, MG
Ancione, M
Madia, A
Levita, A
Citation: E. Spina et al., No effect of reboxetine on plasma concentrations of clozapine, risperidone, and their active metabolites, THER DRUG M, 23(6), 2001, pp. 675-678
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone during combined treatment with paroxetine, THER DRUG M, 23(3), 2001, pp. 223-227
Authors:
Spina, E
Avenoso, A
Facciola, G
Scordo, MG
Ancione, M
Madia, AG
Ventimiglia, A
Perucca, E
Citation: E. Spina et al., Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics, PSYCHOPHAR, 148(1), 2000, pp. 83-89
Authors:
Avenoso, A
Facciola, G
Salemi, M
Spina, E
Citation: A. Avenoso et al., Determination of risperidone and its major metabolite 9-hydroxyrisperidonein human plasma by reversed-phase liquid chromatography with ultraviolet detection, J CHROMAT B, 746(2), 2000, pp. 173-181
Authors:
Spina, E
Avenoso, A
Salemi, M
Facciola, G
Scordo, MG
Ancione, M
Madia, A
Citation: E. Spina et al., Plasma concentrations of clozapine and its major metabolites during combined treatment with paroxetine or sertraline, PHARMACOPS, 33(6), 2000, pp. 213-217
Authors:
Spina, E
Avenoso, A
Facciola, G
Salemi, M
Scordo, MG
Giacobello, T
Madia, AG
Perucca, E
Citation: E. Spina et al., Plasma concentrations of risperidone and 9-hydroxyrisperidone: Effect of comedication with carbamazepine or valproate, THER DRUG M, 22(4), 2000, pp. 481-485
Authors:
Scordo, MG
Spina, E
Facciola, G
Avenoso, A
Johansson, I
Dahl, ML
Citation: Mg. Scordo et al., Cytochrome P450 2D6 genotype and steady state plasma levels of risperidoneand 9-hydroxyrisperidone, PSYCHOPHAR, 147(3), 1999, pp. 300-305
Authors:
Avenoso, A
Facciola, G
Scordo, MG
Spina, E
Citation: A. Avenoso et al., No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers, THER DRUG M, 21(5), 1999, pp. 577-579
Authors:
Facciola, G
Avenoso, A
Scordo, MG
Madia, AG
Ventimiglia, A
Perucca, E
Spina, E
Citation: G. Facciola et al., Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders, THER DRUG M, 21(3), 1999, pp. 341-345
Risultati:
1-12
|